LENSAR Inc (LNSR) — Stock Valuation & Research

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract…

LNSR key statistics

Price$7.00
Market cap$85.97M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range4.95-12.94
Beta0.97

Explore LNSR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.